Aflac sells supplemental health and life insurance policies that pay cash benefits directly to policyholders for specific events such as cancer, accidents, and critical illnesses. It has built a major business in Japan alongside its US operations and distributes products largely through worksite and agent channels. The company specializes in voluntary insurance that complements primary coverage and is often purchased through employers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 3,453 | — | 29 | — |
| Q2 2025 | 4,218 | — | 599 | — |
| Q3 2025 | 4,793 | — | 1,639 | — |
| Q4 2025 | 4,891 | — | 1,379 | — |
| Q1 2026 | 4,408 | 27.7% | 1,019 | 3,413.8% |
| Q2 2026 | 4,194 | -0.6% | 825 | 37.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Cheniere Energy, Inc. (LNG), MPLX LP (MPLX), Cardinal Health, Inc. (CAH), ONEOK, Inc. (OKE), Nucor Corporation (NUE), Truist Financial Corporation (TFC)